BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35808)

  • 1. Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm.
    Davis M
    Psychopharmacology (Berl); 1979 Mar; 62(1):1-7. PubMed ID: 35808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam.
    Tizzano JP; Griffey KI; Schoepp DD
    Pharmacol Biochem Behav; 2002 Sep; 73(2):367-74. PubMed ID: 12117591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine and naloxone: effects on conditioned fear as measured with the potentiated startle paradigm.
    Davis M
    Eur J Pharmacol; 1979 Mar; 54(4):341-7. PubMed ID: 436933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepam.
    Melia KR; Davis M
    Physiol Behav; 1991 Mar; 49(3):603-11. PubMed ID: 1648244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man.
    Bitsios P; Philpott A; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 1999; 13(3):226-34. PubMed ID: 10512076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control conditions in the fear-potentiated startle response paradigm.
    Joordens RJ; Hijzen TH; Peeters BW; Olivier B
    Neuroreport; 1997 Mar; 8(4):1031-4. PubMed ID: 9141086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm.
    Davis M; Redmond DE; Baraban JM
    Psychopharmacology (Berl); 1979 Oct; 65(2):111-8. PubMed ID: 117478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and pharmacological validation of an integrated fear-potentiated startle and prepulse inhibition paradigm.
    Zhang M; Li M
    Behav Brain Res; 2016 Jul; 307():176-85. PubMed ID: 27059335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effect of sex and estrous cycle on the fear potentiated startle response in rats.
    Zhao Y; Bijlsma EY; Verdouw MP; Groenink L
    Behav Brain Res; 2018 Oct; 351():24-33. PubMed ID: 29803653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
    Nevins ME; Anthony EW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):248-54. PubMed ID: 7905528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm.
    Kehne JH; Cassella JV; Davis M
    Psychopharmacology (Berl); 1988; 94(1):8-13. PubMed ID: 2894703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oxytocin on background anxiety in rats with high or low baseline startle.
    Ayers L; Agostini A; Schulkin J; Rosen JB
    Psychopharmacology (Berl); 2016 Jun; 233(11):2165-2172. PubMed ID: 27004789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone.
    Winslow JT; Noble PL; Davis M
    Biol Psychiatry; 2007 Feb; 61(3):389-95. PubMed ID: 16730332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepines have no effect on fear-potentiated startle in humans.
    Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN
    Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological analysis of fear-potentiated startle.
    Davis M
    Braz J Med Biol Res; 1993 Mar; 26(3):235-60. PubMed ID: 8257926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazepam blocks fear-potentiated startle in humans.
    Patrick CJ; Berthot BD; Moore JD
    J Abnorm Psychol; 1996 Feb; 105(1):89-96. PubMed ID: 8666715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
    Davis M; Cassella JV; Kehne JH
    Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fear-potentiated startle: a neural and pharmacological analysis.
    Davis M; Falls WA; Campeau S; Kim M
    Behav Brain Res; 1993 Dec; 58(1-2):175-98. PubMed ID: 8136044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous slow release of low levels of diazepam produces tolerance to its depressant and anxiolytic effects on the startle reflex.
    Davis M; Gallager DW
    Eur J Pharmacol; 1988 May; 150(1-2):23-33. PubMed ID: 2900153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory-mediated fear-potentiated startle.
    Paschall GY; Davis M
    Behav Neurosci; 2002 Feb; 116(1):4-12. PubMed ID: 11895182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.